CA Stock MarketDetailed Quotes

RX Biosyent Inc

Watchlist
  • 11.980
  • +0.370+3.19%
15min DelayMarket Closed Dec 13 16:00 ET
138.90MMarket Cap20.00P/E (TTM)

About Biosyent Inc Company

Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product includes FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Repagyn, and Tibella.m.

Company Profile

SymbolRX
Company NameBiosyent Inc
Founded1947
MarketTSX
Fiscal Year Ends12-31
Address2476 Argentia Road Suite 402
CityMississauga
CountryCAN
Zip CodeL5N 6M1
Phone+1 905 206-0013

Company Executives

  • Name
  • Position
  • Salary
  • Rene C. Goehrum
  • Chairman of the Board, President and Chief Executive Officer
  • --
  • Robert March
  • Vice President, Finance and Chief Financial Officer
  • --
  • Joost van der Mark
  • Vice President, Corporate Development
  • --
  • Kevin Wilson
  • Vice President, Community Health Business
  • --
  • Dr. Navid Ashrafi, M.D.
  • Director, Medical and Regulatory Affairs
  • --
  • Joseph Arcuri
  • Independent Director
  • --
  • Peter D. Lockhard
  • Lead Independent Director
  • --
  • Sara C. Elford
  • Independent Director
  • --
  • Stephen Wilton
  • Independent Director
  • --
  • Larry Andrews
  • Independent Director
  • --